SSH - LAUREL HIGHLANDS INC — History
CCN 392036 | 3-year financial timeline | COVID resilience: 24/100
🛡️ Public data only — no PHI permitted on this instance.
$11M
Latest Revenue (FY2022)
-6.7%
Revenue CAGR (3yr)
5.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $12M | $14M | $11M | -22.7% | -6.7% |
| Operating Expenses | $10M | $10M | $10M | -1.4% | +1.2% |
| Operating Margin | 19.2% | 25.6% | 5.0% | -80.3% | -48.8% |
| Net Income | $2M | $4M | $1M | -84.8% | -52.2% |
| Licensed Beds | 40 | 40 | 40 | +0.0% | +0.0% |
| Total Patient Days | 7,253 | 6,817 | 6,488 | -4.8% | -5.4% |
| Medicare Day % | 39% | 21% | 40% | +93.5% | +1.5% |
| Medicaid Day % | nan% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 24/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -12.9% ($12M → $11M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
-6.7%
This Hospital
+7.6%
State Avg
Latest Margin
5.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $10M | -2.1% |
| FY2024 (proj) | $9M | -9.2% |
| FY2025 (proj) | $8M | -16.2% |